ArticleRheumatology (Oxford, England)2023

Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus.

Chris Wincup et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.